Skip to main content
NVDA-2.56%AAPL+2.09%GOOGL-0.15%MSFT+0.01%AMZN+0.07%TSM-1.00%SPCX+1.78%AVGO+0.04%META+0.01%TSLA-0.58%SKHY-4.03%MU-4.48%BRK-B-0.15%LLY+0.70%JPM-0.44%AMD-2.55%WMT+0.12%V-0.15%XOM+0.11%ASMLa-1.82%JNJ-0.04%INTC-4.41%MA-0.47%0700.HK-1.94%ORCL-2.24%1398.HK+0.79%BAC-0.50%ABBV+0.55%CSCO-0.53%CVX-0.46%COST+0.03%LRCX-3.93%KO+0.97%CAT-1.09%AMAT-2.32%0005.HK-0.78%AP2d-1.57%UNH-0.67%DELL-2.77%HSBA.L-1.17%MS-0.21%PG-0.22%GE-0.11%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.11%HD-0.96%GS-0.39%0939.HK+1.66%NZDJPY-2.69%AUDJPY-1.94%CHFJPY-1.66%USDJPY-1.50%NZDCAD-1.38%GBPJPY-1.38%EURJPY-1.37%EURNZD+1.37%CADJPY-1.32%GBPNZD+1.32%NZDUSD-1.22%NZDCHF-1.06%USDNOK+0.91%EURNOK+0.88%CHFNOK+0.80%AUDNZD+0.78%USDZAR+0.76%EURZAR+0.73%USDSEK+0.70%NOKJPY-0.68%EURSEK+0.66%GBPZAR+0.66%AUDCAD-0.65%AUDDKK-0.62%CHFSEK+0.59%EURAUD+0.58%GBPAUD+0.54%AUDSGD-0.49%USDMXN+0.46%AUDUSD-0.45%USDTHB+0.45%GBPTRY+0.41%NZDSGD-0.33%GBPHKD+0.32%CADCHF+0.32%AUDCHF-0.29%GBPMXN-0.28%EURCHF+0.28%AUDNOK+0.26%GBPCHF+0.26%USDPLN+0.25%EURPLN+0.21%USDCAD-0.17%USDCHF+0.17%USDILS+0.16%USDSGD+0.16%EURUSD+0.13%EURSGD+0.12%GBPUSD+0.11%USDTRY+0.11%EURCZK-0.08%GBPCAD-0.08%SGDJPY+0.08%USDCNH+0.06%NZDMXN-0.05%EURHKD-0.05%EURCAD-0.05%CHFSGD+0.04%EURCNH+0.04%USDCOP-0.04%EURGBP+0.04%USDDKK+0.04%GBPSGD+0.03%PLNJPY-0.01%USDHKD+0.01%EURDKK0.00%XPTUSD-4.93%HG1-4.65%GAGUSD-4.13%XAGUSD-4.13%UKOIL+3.72%USOIL+3.33%SUGAR+1.74%COCOA+1.05%GAUUSD-0.89%XAUUSD-0.89%S1+0.76%COTTON+0.71%BTCUSD-1.46%ETHUSD-1.30%USDTUSD-0.02%XRPUSD-2.93%SOLUSD-1.81%TRXUSDT-0.03%ZECUSDT-6.32%DOGEUSD-3.23%XMRUSDT-2.05%LINKUSD-1.53%XLMUSD-2.24%BCHUSDT-11.18%LTCUSD-2.07%UNIUSD-3.99%TONUSD+24.88%HBARUSDT-2.10%SUIUSD-3.84%TAOUSDT-5.84%AAVEUSD-3.26%DOTUSDT-3.07%ICPUSDT-1.15%ONDOUSDT-3.26%WLDUSDT-3.39%ATOMUSDT-4.43%ARBUSDT+0.43%JUPUSDT-3.82%INJUSDT-5.31%STXUSDT-3.80%FETUSDT-4.15%TIAUSDT-1.39%PYTHUSDT-0.37%SEIUSDT-3.91%IMXUSDT-3.85%GRTUSDT-3.34%WIFUSDT-5.38%OPUSDT-4.00%IOTAUSDT-4.12%POLUSDT-5.95%AXSUSDT-2.90%FARTCOINUSDT-3.37%EOSUSDT-0.93%DYDXUSDT-1.19%ORDIUSDT-1.43%GALAUSDT-5.34%NOTUSDT-2.97%RONINUSDT-2.64%NVDA-2.56%AAPL+2.09%GOOGL-0.15%MSFT+0.01%AMZN+0.07%TSM-1.00%SPCX+1.78%AVGO+0.04%META+0.01%TSLA-0.58%SKHY-4.03%MU-4.48%BRK-B-0.15%LLY+0.70%JPM-0.44%AMD-2.55%WMT+0.12%V-0.15%XOM+0.11%ASMLa-1.82%JNJ-0.04%INTC-4.41%MA-0.47%0700.HK-1.94%ORCL-2.24%1398.HK+0.79%BAC-0.50%ABBV+0.55%CSCO-0.53%CVX-0.46%COST+0.03%LRCX-3.93%KO+0.97%CAT-1.09%AMAT-2.32%0005.HK-0.78%AP2d-1.57%UNH-0.67%DELL-2.77%HSBA.L-1.17%MS-0.21%PG-0.22%GE-0.11%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.11%HD-0.96%GS-0.39%0939.HK+1.66%NZDJPY-2.69%AUDJPY-1.94%CHFJPY-1.66%USDJPY-1.50%NZDCAD-1.38%GBPJPY-1.38%EURJPY-1.37%EURNZD+1.37%CADJPY-1.32%GBPNZD+1.32%NZDUSD-1.22%NZDCHF-1.06%USDNOK+0.91%EURNOK+0.88%CHFNOK+0.80%AUDNZD+0.78%USDZAR+0.76%EURZAR+0.73%USDSEK+0.70%NOKJPY-0.68%EURSEK+0.66%GBPZAR+0.66%AUDCAD-0.65%AUDDKK-0.62%CHFSEK+0.59%EURAUD+0.58%GBPAUD+0.54%AUDSGD-0.49%USDMXN+0.46%AUDUSD-0.45%USDTHB+0.45%GBPTRY+0.41%NZDSGD-0.33%GBPHKD+0.32%CADCHF+0.32%AUDCHF-0.29%GBPMXN-0.28%EURCHF+0.28%AUDNOK+0.26%GBPCHF+0.26%USDPLN+0.25%EURPLN+0.21%USDCAD-0.17%USDCHF+0.17%USDILS+0.16%USDSGD+0.16%EURUSD+0.13%EURSGD+0.12%GBPUSD+0.11%USDTRY+0.11%EURCZK-0.08%GBPCAD-0.08%SGDJPY+0.08%USDCNH+0.06%NZDMXN-0.05%EURHKD-0.05%EURCAD-0.05%CHFSGD+0.04%EURCNH+0.04%USDCOP-0.04%EURGBP+0.04%USDDKK+0.04%GBPSGD+0.03%PLNJPY-0.01%USDHKD+0.01%EURDKK0.00%XPTUSD-4.93%HG1-4.65%GAGUSD-4.13%XAGUSD-4.13%UKOIL+3.72%USOIL+3.33%SUGAR+1.74%COCOA+1.05%GAUUSD-0.89%XAUUSD-0.89%S1+0.76%COTTON+0.71%BTCUSD-1.46%ETHUSD-1.30%USDTUSD-0.02%XRPUSD-2.93%SOLUSD-1.81%TRXUSDT-0.03%ZECUSDT-6.32%DOGEUSD-3.23%XMRUSDT-2.05%LINKUSD-1.53%XLMUSD-2.24%BCHUSDT-11.18%LTCUSD-2.07%UNIUSD-3.99%TONUSD+24.88%HBARUSDT-2.10%SUIUSD-3.84%TAOUSDT-5.84%AAVEUSD-3.26%DOTUSDT-3.07%ICPUSDT-1.15%ONDOUSDT-3.26%WLDUSDT-3.39%ATOMUSDT-4.43%ARBUSDT+0.43%JUPUSDT-3.82%INJUSDT-5.31%STXUSDT-3.80%FETUSDT-4.15%TIAUSDT-1.39%PYTHUSDT-0.37%SEIUSDT-3.91%IMXUSDT-3.85%GRTUSDT-3.34%WIFUSDT-5.38%OPUSDT-4.00%IOTAUSDT-4.12%POLUSDT-5.95%AXSUSDT-2.90%FARTCOINUSDT-3.37%EOSUSDT-0.93%DYDXUSDT-1.19%ORDIUSDT-1.43%GALAUSDT-5.34%NOTUSDT-2.97%RONINUSDT-2.64%
GE

Geron Corporation (GERN)

NASDAQ • Healthcare

$1.4
-$0.11 (-7.3%)
Market open

Last close at September 9, 2026 at 20:00 UTC

Open$1.5
Previous Close$1.4
Day Range$1.4 - $1.51
Avg. Volume (3M)9.5M
Market Cap$898.1M
52 Week Range
$1.04$2.01
Next EarningsIn 55 daysNov 4, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$57.4M100%
Gross Profitminus cost of goods$48.2M84%

In plain terms: out of every $100 in revenue, Geron Corporation currently loses $29.

Fundamentals & Financials

Revenue (TTM)
$204.5M
Net Income (TTM)
-$69.8M
EPS (TTM)
-$0.1
ROA (TTM)
-13.47%
Current Ratio
6.92

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

0.0%Q1 2026-$0.03
+66.7%Q2 2026-$0.01
-125.2%Q3 2026-$0.02
Next

Nov 4

in 55 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About Geron Corporation

Geron Corporation is a NASDAQ-listed biotechnology company focused on imetelstat, a telomerase inhibitor for blood cancers. In FY2025, the company generated $183.9 million in revenue. Geron develops its therapy within the healthcare sector around a single oncology asset designed to target malignant cell biology.

Name
Geron Corporation
CEO
Harout Semerjian
Website
www.geron.com
Industry
Healthcare
Year Founded
1990
Employees
258

Today's Snapshot

AI-generated

GERN opened 1.8% lower at 1.38, while its sector was flat. Geron discussed growing RYTELO sales, its blood-disorder drug, at a healthcare conference.

Trading Volume

Below 10d avg (10.2M)

1.8M

vs S&P 500 Today

Inline with Market

-0.06%

Updated: September 10, 2026 at 14:44 UTC

Technical Indicators

1 Buy1 Neutral6 Sell
GERN, near $1.376, exhibits weak trend characteristics with ADX in the low teens and clear downside momentum: a steeply negative CCI and a slightly negative MACD accompany muted RSI. The stock trades below short-, medium- and long-term moving averages, including the 200-day pivot around 1.44, indicating pervasive weakness. Volatility is relatively high for the price with ATR roughly 6.3%, and OBV is strongly negative, implying persistent distribution. The classic pivot sits above the current price and may act as resistance. Technical takeaway: Sell.
All signals
  • EMA (5 indicators)$1.42 - $1.49
    Sell
  • RSI (14)41.17
    Neutral
  • Stochastic %K (14, 3, 3)14.51
    Buy
  • MACD Level (12, 26)-0.00
    Sell

Peers & Related Assets

VIRVir Biotechnology, Inc.
$10.81-3.3%
AVBPArriVent BioPharma, Inc.
$29.79-1.6%
TYRATyra Biosciences, Inc.
$22.01-17.7%
REPLReplimune Group, Inc.
$14.45-2.2%
SVRASavara Inc.
$5.42-2.0%
ARVNArvinas, Inc.
$8.76-3.5%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.